Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dali Wang

Showing results (301-310 of 312) with videos related to

Pageof 32
Sort By:
Emerging Infectious Diseases|January 19, 2017
Changing Epidemiology of Human Brucellosis, China, 1955-2014Shengjie Lai, Hang Zhou, Weiyi Xiong, et al.
BMJ (Clinical Research Ed.)|June 8, 2019
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trialYilong Wang, Weiqi Chen, Yi Lin, et al.
Therapeutic Advances in Medical Oncology|January 6, 2022
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapyXiao Chang, Junqiang Chen, Wencheng Zhang, et al.
Frontiers in Oncology|November 28, 2022
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinomaWeiming Han, Wei Deng, Qifeng Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2026
Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analysesWei Guo, Liang Zhao, Xiaowei Chen, et al.
Journal of Hypertension|February 8, 2017
Blood pressure reduction in acute ischemic stroke according to time to treatment: a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trialTan Xu, Yonghong Zhang, Xiaoqing Bu, et al.
Asia-Pacific Journal of Clinical Oncology|September 14, 2022
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up studyFanghui Zhao, Archana Jastorff, Ying Hong, et al.
JAMA|November 19, 2013
Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trialJiang He, Yonghong Zhang, Tan Xu, et al.
BMJ (Clinical Research Ed.)|October 9, 2023
Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trialLiping Liu, Xuewei Xie, Yuesong Pan, et al.
Oncoimmunology|September 18, 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAnnalisa Adamo, Cristina Frusteri, Sara Pilotto, et al.
Pageof 32

Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Emerging Infectious Diseases|January 19, 2017
Changing Epidemiology of Human Brucellosis, China, 1955-2014Shengjie Lai, Hang Zhou, Weiyi Xiong, et al.
BMJ (Clinical Research Ed.)|June 8, 2019
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trialYilong Wang, Weiqi Chen, Yi Lin, et al.
Therapeutic Advances in Medical Oncology|January 6, 2022
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapyXiao Chang, Junqiang Chen, Wencheng Zhang, et al.
Frontiers in Oncology|November 28, 2022
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinomaWeiming Han, Wei Deng, Qifeng Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2026
Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analysesWei Guo, Liang Zhao, Xiaowei Chen, et al.
Journal of Hypertension|February 8, 2017
Blood pressure reduction in acute ischemic stroke according to time to treatment: a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trialTan Xu, Yonghong Zhang, Xiaoqing Bu, et al.
Asia-Pacific Journal of Clinical Oncology|September 14, 2022
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up studyFanghui Zhao, Archana Jastorff, Ying Hong, et al.
JAMA|November 19, 2013
Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trialJiang He, Yonghong Zhang, Tan Xu, et al.
BMJ (Clinical Research Ed.)|October 9, 2023
Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trialLiping Liu, Xuewei Xie, Yuesong Pan, et al.
Oncoimmunology|September 18, 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAnnalisa Adamo, Cristina Frusteri, Sara Pilotto, et al.
Pageof 32